Russian Federation Health News

Fleishman-Hillard Vanguard provided support for Reckitt Benckiser in organizing a press tour of the Russian mass-media to London.

Esther Dyson, a Chairman of EDventure Holdings, Peter Frishauf, Founder of Medscape, and by Milena Adamian, MD, a Cardiologist and Founder of the Life Sciences Angel Network entered VitaPortal Advisory Council.

Artezio NA General Manager Mr. Sina Adibi participates in the 10th annual BioTech Symposium in Philadelphia, PA on October 27-28.

Artezio NA Vice President for Business Development participates in the fourth annual AdvaMed 2010 – the MedTech Conference in Washington, D.C. on October 18-20.

Artezio-NA managers took part in the 9th Annual Contracting and Outsourcing Conference and Tabletop Exhibition in New Brunswick, NJ, devoted to outsourcing in pharmaceutical and biotech industries.

Live view from Moscow city centre webcam, looking over the Moskva ann towards the city centre as a blanket of smog engulfs the city

Artezio participated in 19th annual Partnerships in Clinical Trials event in Orlando on April, 12–14. The company keeps following the trends in healthcare software development.

The Research Alliance has just released a global study on 'Health & Food' conducted worldwide earlier this year; in 15 countries. The study was a mix of quantitative and qualitative techniques.

A project to produce bicuspid and develop tricuspid artificial heart valves has been approved by the Supervisory Council of RUSNANO. Total budget for the project is 1.488 billion rubles of which RUSNANO will provide 930 million rubles.

A project to produce a number of pharmaceuticals recently won approval from the Supervisory Council of RUSNANO. The total budget for the project is 831 million rubles.

Artezio, a leading Russian provider of software development outsourcing services is teaming with dbMotion, a global leader of health interoperability solutions, to develop dbMotion’s cutting edge healthcare information technology software.

A new asthma treatment without medication has recently been announced and claimed effective by a group of Russian researchers from Dinamika company who have found and tested it, and are now ready to introduce the invention to the world market.